These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 11126367)
1. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells. Liu YN; Kang BB; Chen JH Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233 [TBL] [Abstract][Full Text] [Related]
3. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113 [TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells. Turner EC; Kinsella BT J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563 [TBL] [Abstract][Full Text] [Related]
6. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601 [TBL] [Abstract][Full Text] [Related]
7. A role for Octamer binding protein motifs in the regulation of the proximal preprotachykinin-A promoter. Fiskerstrand CE; Newey P; McGregor GP; Gerrard L; Millan F; Quinn JP Neuropeptides; 2000 Dec; 34(6):348-54. PubMed ID: 11162291 [TBL] [Abstract][Full Text] [Related]
8. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229 [TBL] [Abstract][Full Text] [Related]
10. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter. Chen JH; Wright CD Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features. Lee Y; Johnson LF Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787 [TBL] [Abstract][Full Text] [Related]
12. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter. Yang HM; Do HJ; Oh JH; Kim JH; Choi SY; Cha KY; Chung HM; Kim JH J Cell Biochem; 2005 Nov; 96(4):821-30. PubMed ID: 16149048 [TBL] [Abstract][Full Text] [Related]
13. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132 [TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells. Ma H; Urquidi V; Wong J; Kleeman J; Goodison S Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399 [TBL] [Abstract][Full Text] [Related]
15. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein. Lou Z; Maher VM; McCormick JJ Gene; 2005 May; 351():51-9. PubMed ID: 15857802 [TBL] [Abstract][Full Text] [Related]
17. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice. Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
19. Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element. Sterling K; Bresnick E Mol Pharmacol; 1996 Feb; 49(2):329-37. PubMed ID: 8632766 [TBL] [Abstract][Full Text] [Related]
20. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]